Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Australia-based Telix Pharmaceuticals inks oncology deal with Eli Lilly
Bio Spectrum Asia
Mon, 04/11/22 - 10:36 am
Telix Pharmaceuticals
Eli Lilly
radiopharmaceuticals
olaratumab
soft tissue sarcoma
Ukraine war, China's COVID lockdown and more could weigh on J&J's early-year performance—and it may not be alone: analysts
Fierce Pharma
Tue, 04/5/22 - 11:53 am
JNJ
pandemic
Ukraine
COVID-19
Merck
Pfizer
Eli Lilly
Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly's Trulicity
Fierce Pharma
Wed, 03/30/22 - 11:11 am
Novo Nordisk
Ozempic
diabetes
FDA
Eli Lilly
Trulicity
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Roche
tiragolumab
Giredestrant
Sanofi
Eli Lilly
tirzepatide
Novo Nordisk
GSK
Pfizer
RSV
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Eli Lilly
lebrikizumab
Demira
Sanofi
Regeneron
Dupixent
atopic dermatitis
Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more
MedCity News
Mon, 03/28/22 - 10:17 am
FDA
Pfizer
etrasimod
Argenxy
efgartigimod
Aligos Therapeutics
Vallon Pharmaceuticals
Adderall
ORIC Pharmaceuticals
ORIC-101
Neurana Pharmaceuticals
tolperisone
Eli Lilly
sintilimab
In Expected Decision, FDA Rejects Lilly's Sintilimab in NSCLC
BioSpace
Thu, 03/24/22 - 10:58 am
Eli Lilly
sintilimab
FDA
NSCLC
Eli Lilly CEO's pay falls 9% to $21.5M—no thanks to pension declines
Fierce Pharma
Mon, 03/21/22 - 10:11 am
Eli Lilly
Pharma CEOs
Dave Ricks
executive pay
Could This Be Eli Lilly's Next Blockbuster Drug?
Motley Fool
Sun, 03/20/22 - 11:01 pm
Eli Lilly
mirikizumab
ulcerative colitis
Eli Lilly takes more heat for campaign contributions to election objectors
Fierce Pharma
Fri, 03/18/22 - 10:52 am
Eli Lilly
campaign donations
PAC
What now for low-cost PD-(L)1 competition?
EP Vantage
Fri, 03/18/22 - 10:25 am
FDA
anti-PD-L1
Innovent
Eli Lilly
Lilly, BI-Partnered Kidney Trial Stopped Early Due to Positive Results
BioSpace
Wed, 03/16/22 - 11:20 pm
Eli Lilly
Boehringer Ingelheim
clinical trials
chronic kidney disease
empagliflozin
Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia
Endpoints
Tue, 03/15/22 - 11:36 pm
Russia
Ukraine
Novartis
Eli Lilly
AbbVie
Erasca, Eli Lilly partner for colorectal cancer therapy trial
Pharmaceutical Business Review
Fri, 03/11/22 - 10:37 am
Erasca
Eli Lilly
clinical trials
ERAS-007
colorectal cancer
A trio of amyloid-targeted Alzheimer's drugs will soon see key results, but an analyst predicts only 50-50 odds for one
Endpoints
Wed, 03/9/22 - 11:09 pm
Alzheimer's disease
clinical trials
Roche
Eli Lilly
Biogen
donanemab
lecanemab
gantenerumab
As Eli Lilly grows beyond Research Triangle Park, biopharmas big and small are tapping North Carolina's 'limitless' potential
Fierce Pharma
Tue, 03/8/22 - 10:22 am
North Carolina
RTP
Eli Lilly
Amgen
Jaguar Gene Therapy
Thermo Fisher
biotech
biotech hubs
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
Europe
AstraZeneca
Farxiga
UK Recovery trial confirms Covid benefit for Olumiant
EP Vantage
Mon, 03/7/22 - 09:55 am
Eli Lilly
clinical trials
COVID-19
olumiant
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
Eli Lilly's Medicaid rebate payments under fire as whistleblower lawsuit heads to trial
Fierce Pharma
Wed, 03/2/22 - 10:33 am
Eli Lilly
Medicaid
rebate payments
whistleblowers
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »